Baqsimi (glucagon)

pCPA File Number: 21184

Negotiation Status:

Concluded with an LOI

Indication(s):

Severe Hypoglycemia

Sponsor/Manufacturer:

Eli Lilly Canada Inc.

CDA-AMC Project Number:

SR0626-000

pCPA Engagement Letter Issued:

2020-12-14

Negotiation Process Concluded:

2021-11-22